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ABSTRACT
Background Expertise and resources may be important
determinants of outcome for extremely preterm babies.
We evaluated the effect of place of birth and perinatal
transfer on survival and neonatal morbidity within a
prospective cohort of births between 22 and 26 weeks
of gestation in England during 2006.
Methods We studied the whole population of 2460
births where the fetus was alive at the admission of the
mother to hospital for delivery. Outcomes to discharge
were compared between level 3 (most intensive) and
level 2 maternity services, with and without transfers,
and by activity level of level 3 neonatal unit; ORs were
adjusted for gestation at birth and birthweight for
gestation (adjusted ORs (aOR)).
Findings Of this national birth cohort, 56% were born
in maternity services with level 3 and 34% with level 2
neonatal units; 10% were born in a setting without
ongoing intensive care facilities (level 1). When
compared with level 2 settings, risk of death in level 3
services was reduced (aOR 0.73 (95% CI 0.59 to 0.90)),
but the proportion surviving without neonatal morbidity
was similar (aOR 1.27 (0.93 to 1.74)). Analysis by
intended hospital of birth conﬁrmed reduced mortality in
level 3 services. Following antenatal transfer into a level
3 setting, there were fewer intrapartum or labour ward
deaths, and overall mortality was higher for those
remaining in level 2 services (aOR 1.44 (1.09 to 1.90)).
Among level 3 services, those with higher activity had
fewer deaths overall (aOR 0.68 (0.52 to 0.89)).
Interpretation Despite national policy, only 56% of
births between 22 and 26 weeks of gestation occurred
in maternity services with a level 3 neonatal facility.
Survival was signiﬁcantly enhanced following birth in
level 3 services, particularly those with high activity; this
was not at the cost of increased neonatal morbidity.
INTRODUCTION
Survival and later neurological and developmental
outcomes for extremely premature babies remain of
concern because of signiﬁcant mortality and mor-
bidity.1 2 In the UK, neonatal care services have
developed largely in response to local needs,3 in
contrast to practice in many other countries, where
highly regionalised systems have developed.4 In
2003, there was a nationally commissioned review5
that subsequently led to the development of
managed neonatal clinical networks in England and
increased centralisation of care for babies born at
26 weeks of gestation or less. However, there has
been a paucity of data from the UK examining the
relationship of birth at extremely low gestational
ages to the expertise in the hospital of birth and a
continuing reluctance among practitioners to
support the principle that centralisation of specialist
services will improve outcomes for this group
within the UK model of care.6 Thus, it is important
to assess the impact that the development of neo-
natal networks may have had on outcome for this
particular group.
In 2006, we carried out a national population
study of births in England between 22 and 26 com-
pleted weeks of gestation (EPICure 2), from which
survival and short-term morbidity data and
outcome at 3 years of age have been published.1 2
This report evaluates the hypothesis that birth in,
or transfer to, designated referral centres is accom-
panied by lower rates of mortality and morbidity
among survivors.
POPULATION
Details of all births reported between 22 and
26 weeks’ gestation were collected prospectively in
all 182 maternity hospitals in England during
2006. Births to mothers not usually resident in
England were excluded. This study was based on
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What is already known on this topic
▸ International data suggest that survival for
babies admitted for neonatal intensive care is
improved in regional centres.
▸ Previous data are difﬁcult to interpret because
of the confounding effect of antenatal and
postnatal transfer.
What this study adds
▸ Survival is greater in specialist hospitals in
England providing neonatal intensive care and
is further improved in higher activity services.
▸ This improvement is primarily achieved by a
reduction in fetal deaths before delivery, and
neonatal deaths in the delivery room and over
the ﬁrst week.
▸ Women who book for their care at specialist
hospitals have lower mortality compared with
those booking at local (non-specialist)
hospitals, although antenatal transfer does
result in a group of babies with improved
survival chances.
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the complete population of mothers with a live fetus at the
point of the hospital admission that led to delivery.
METHODOLOGY
Information was collected on place of maternal booking and
delivery for all births, together with details for all livebirths of
neonatal transfers and major neonatal morbidities to discharge
from hospital. Further details on the neonatal data collection
process and population outcomes have been reported
previously.1
For this report, a ‘service’ comprises the maternity service and
its associated neonatal unit, categorised by level of neonatal
unit, using the agreed local designation of each neonatal unit
(level 1, 2 or 3), based on guidance in the 2003 national review.
Level 1 services were hospitals with a level 1 neonatal unit and
would aim to transfer out any woman whose baby was expected
to need intensive care; level 2 services would generally aim to
transfer out women expected to deliver before 27 weeks of ges-
tation; level 3 services would provide the whole range of
medical neonatal intensive care.
We further categorised level 3 neonatal units based on activity
data collected by questionnaire, based on that of the United
Kingdom Neonatal Stafﬁng Study (UKNSS),7 sent during the
autumn of 2006 to named EPICure contacts in each hospital.
The EPICure perinatal steering group categorised units into
high activity (≥2000 days respiratory support (ventilation or
continuous positive airways pressure) per year and more than
four consultants with more than 50% of their time dedicated to
neonatology), medium activity (500–1999 days of respiratory
support and at least one consultant with more than 50% of
their time dedicated to neonatology) and low activity
(<500 days and no dedicated neonatal consultant). Only level 3
services with units categorised as ‘high’ or ‘medium’ activity
services were used in our analysis.
In this paper, an antenatal transfer was deﬁned as any transfer
into a level 3 service between booking and delivery; neonatal
transfers were deﬁned as those occurring within 24 h of birth.
Later transfers, primarily for surgery or back transfer to the
mother’s local hospital, were not considered. Neonatal morbid-
ity was deﬁned as one or more of retinopathy of prematurity
requiring retinal surgery, moderate or severe bronchopulmonary
dysplasia (oxygen or respiratory support at 36 weeks’ post-
menstrual age), a severe brain injury (haemorrhagic parenchymal
infarct, cystic changes or hydrocephalus on cerebral ultrasound)
or necrotising enterocolitis managed by laparotomy.
Statistical analysis
The principal aim of this study was to determine the effect of
the categorisation of the service providing care at birth and the
inﬂuence of transfer before and after delivery. Only gestation
and weight for gestation at birth, which are the most important
determinants of survival,8 were used as confounders, unless
otherwise stated.
The case mix of transferred mothers or babies is likely to be
different from those who are not transferred. We addressed
potential bias accruing from this in the following ways: analysis
was ﬁrst carried out comparing all babies born in level 3 services
with all those born in level 2 services. This comparison was
repeated after excluding births to women transferred antenatally
to a level 3 service. We then compared the population of ante-
natal transfers to a level 3 service to the population born and
remaining in level 2 or 3 services, respectively. This was
repeated for neonatal transfers comparing all transfers to babies
admitted to level 2 or 3 neonatal units but not transferred. We
also considered outcomes for babies based on the hospital at
which the woman ﬁrst booked to have her care, which approxi-
mates to level 2 births plus antenatal transfers and may be con-
sidered to be a ‘intention to deliver’ analysis. For these analyses,
crude and adjusted ORs and their 95% CIs were calculated
using logistic regression.
Time-speciﬁc mortality outcomes were assessed to determine
whether the risk/beneﬁts were similar at all stages of the clinical
pathway. Using logistic regression, we calculated adjusted ORs
(aORs) divided into deaths before delivery, delivery room
deaths, deaths after neonatal unit admission before 7 days,
between 7 and 28 days and after 28 days but before discharge.
In each case, the aOR is based on the population still alive at
the beginning of the time period under consideration. These
analyses were structured as described in the previous paragraph.
We then evaluated bias that might occur from preferential
treatment of multiple births by analysing only singleton preg-
nancies and the pattern of important determinants of perinatal
Figure 1 Population of births
reported to the EPICure 2 study by
place of birth and transfer status,
indicating the population of babies
included in antenatal transfer,
neonatal transfer and activity analyses.
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outcome: administration of antenatal steroids in order to reduce
neonatal lung disease, no active intervention for the baby after
birth, being alive with heart rate >100 at 5 min (excluding
those with no active intervention), admission for neonatal care
and (for admissions) the Clinical Risk Index for Babies II
(CRIB-II) score.9
For each analysis, we also report the p value for a Wald test
of the overall signiﬁcance of place of birth, activity level, ante-
natal or postnatal transfer as appropriate. All statistical analyses
were performed using Stata V.12 (StataCorp LP, College Station,
Texas, USA).
RESULTS
Among the 182 hospitals with consultant-led obstetric services,
46 were reported to have level 3, 84 level 2 and 52 level 1
neonatal units. Using the stafﬁng and activity data collected for
this study, 24 of the level 3 neonatal units were categorised as
high activity, 21 as medium activity and 1 as low activity.
There were 2460 births at 22–26 weeks of gestation where
the fetus was alive when the mother presented to hospital in her
delivery admission, of which 244 (9.9%) occurred in level 1 ser-
vices, 829 (33.7%) in level 2 services and 1387 (56.4%) in level
3 services. In total, 382 women were transferred to level 3
services before birth (440 fetuses) and 288 babies were neonatal
transfers within 24 h of birth (ﬁgure 1).
Mortality
Place of birth: Survival differed signiﬁcantly by place of birth
(p<0.0001). The proportion of stillbirths and delivery room
deaths was lowest in level 3 services (23%) and highest in level
Table 1 Time-specific mortality and morbidity to discharge from hospital for all births in England in 2006 between 22 and 26 weeks of
gestation
Outcome
Level 1
services
(n=244)
Level 2
services
(n=829)
Level 3
services
(n=1387) p Value*
Adjusted OR (95% CI) based on population
alive at start of time period
Antenatal death 77 32% 174 21% 208 15% <0.0001 0.81 (0.63 to 1.04)
Delivery room deaths 43 18% 143 17% 148 11% <0.001 0.55 (0.39 to 0.77)
Neonatal unit deaths <7 days 38 16% 116 14% 168 12% <0.0001 0.65 (0.49 to 0.86)
All early neonatal deaths 81 33% 259 31% 316 23% <0.0001 0.59 (0.46 to 0.75)
Late neonatal death (7–28 days) 12 5% 56 7% 122 9% 0.999 0.94 (0.66 to 1.33)
Death 29 days to discharge 6 2% 35 4% 86 6% 0.976 1.11 (0.72 to 1.72)
All deaths 176 72% 524 63% 732 53% <0.0001 0.73 (0.59 to 0.90)
Alive on admission Live births Admission to Neonatal unit
Survivors without morbidity† 19 8% 70 8% 157 11% 0.017 1.27 (0.93 to 1.74) 1.25 (0.91 to 1.71) 1.24 (0.90 to 1.71)
Survivors only
Percent without morbidity† 28% 23% 24% 0.769 1.13 (0.81 to 1.57)
OR (95% CI) for births in level 3 versus level 2 services adjusted for gestational age and birthweight for gestation.
Heterogeneity of effect of unit level across gestational age found for late neonatal deaths only (p=0.037).
*Significance of χ2 for trend of unadjusted ORs.
†As defined in methods: retinopathy, bronchopulmonary dysplasia, brain injury, necrotising enterocolitis.
Figure 2 Mortality by place of birth,
perinatal transfer and high and
medium activity level 3 services for
babies born in England in 2006 at 26
completed weeks of gestation or less.
GA, gestational age in weeks; BW,
birthweight for gestation as ‘z’ score;
L2/L3, level of service; ANT, antenatal
transfer; NNT, neonatal transfer; CRIB,
clinical risk index for babies II score9;
ANS, any antenatal steroid given to
mother.
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1 services (42%; table 1). The median age of death among neo-
natal unit admissions was earlier for births in level 1 services
(median 2 days) compared with level 2 services (5 days) or level
3 services (10 days). Births in level 1 services were excluded
from further analysis.
Overall mortality was lower in level 3 compared with level 2
services (OR 0.65 (95% CI 0.55 to 0.78)), and following adjust-
ment for gestational age and birthweight for gestation was only
marginally attenuated (aOR 0.73 (0.59 to 0.90)). There were
also few differences when babies that were transferred either
antenatally or postnatally were excluded. Considering all babies
but including transfer status (antenatal or postnatal) as a covari-
ate in the model does not materially alter the mortality risk
(ﬁgure 2).
Antenatal transfer: The transferred population had lower
mortality compared with those who booked and were born in
either level 3 or level 2 services (crude ORs 1.48 (1.26 to 1.75)
and 2.21(1.87 to 2.61), respectively; p<0.0001 for both). After
adjustment, babies born to mothers who were not transferred
from a level 2 service had an increased odds of death compared
with those who were transferred (aOR 1.44 (1.09 to 1.90)).
However, there was no difference in survival between those
transferred antenatally into and those booked and born in level
3 services (aOR 1.08 (0.83 to 1.41); ﬁgure 2).
Hospital of booking: As the women who are transferred out
may represent those with the highest chance of good outcomes,
we considered the same population but allocated to the category
of hospital where each woman booked for maternity care, as
opposed to the hospital where delivery occurred. Babies of
women booked in level 3 services still had reduced mortality
compared with babies of women booked in level 2 services
(aOR 0.79 (0.63 to 0.98)).
Neonatal transfer: No differences were found in survival for
babies postnatally transferred compared with those who were
born and remained in level 2 or level 3 services.
Time-speciﬁc mortality outcomes
Place of birth
Differences in survival for babies born in level 3 services occur
early in the perinatal period (table 1 and ﬁgure 3). There were
fewer deaths antenatally, in the delivery room and during the
ﬁrst 7 days after birth in level 3 compared with level 2 services;
reﬂected in the proportions surviving to hospital discharge:
36.8% in level 2 services, and 47.2% in level 3 services. After
adjustment, only fetal and early neonatal deaths (aOR 0.59
(0.46 to 0.75)) and overall mortality remained statistically
signiﬁcant.
Antenatal transfer
For women who were not transferred into a level 3 service, the
adjusted odds for the fetus of antenatal death (aOR 1.52 (1.03
to 2.26)), overall early neonatal deaths (aOR 1.49 (1.10 to
2.02)) and deaths to discharge were signiﬁcantly higher than for
those who were transferred (table 2). There were no signiﬁcant
differences in outcomes for the transferred cases compared with
those booked and delivered in hospitals with level 3 services.
Postnatal transfer
The results for postnatal transfer show few differences in
mortality between neonatal transfer (NNT) and babies not
Figure 3 Kaplan–Meier plots of survival by gestational week for babies born at 23–26 weeks of gestation in level 3 and level 2 centres in
England in 2006. Antenatal deaths are plotted as t=1 and delivery room outcomes care as t=2, with admission to neonatal unit as t=3 and
subsequently postnatal age in days to 40 weeks postmenstrual age.
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transferred (table 3). Of note early neonatal deaths are more
common in non-transferred babies admitted to level 2, implying
perhaps that the sickest babies are not transferred.
Survival without morbidity
In contrast to mortality, neonatal morbidity does not appear to
vary signiﬁcantly with place of birth (table 1). The proportions
of survivors without morbidity are similar for those born in hos-
pitals with level 3 services (11%) compared with those with
level 2 (8%), either considering the whole population (11% vs
8%, respectively) or only those who survived (23% vs 24%,
respectively).
There was no evidence of an association between antenatal
transfer and survival without morbidity compared with babies
born in either level 2 or level 3 services, although the ORs were
of a similar order in favour of antenatal transfer in each com-
parison (table 2). In contrast, babies born in centres with level 3
neonatal facilities have signiﬁcantly higher odds of survival
without morbidity compared with babies transferred in after
birth (OR 1.92 (1.02 to 3.60)).
There was no evidence of signiﬁcant variation in speciﬁc mor-
bidities between groups (not shown).
Activity in level 3 services
For all mortality outcomes, unadjusted ORs were lower in high-
activity units compared with medium activity, and the difference
widened after adjustment for gestation and birthweight for ges-
tation (table 4 and ﬁgure 2). There was no evidence for differ-
ences in time-speciﬁc mortality, nor was there any difference in
survival without morbidity in high-throughput units compared
with low-throughput units (aOR 0.79 (0.55 to 1.14)) or in the
proportion surviving without morbidity among survivors (aOR
0.69 (0.47 to 1.02)).
Further analyses
Using data only from singleton pregnancies reﬂected the whole
population analysis and did not alter our conclusions (see online
supplementary tables S1 and S2).
We next investigated whether there were differences in pre-
speciﬁed determinants of outcome.
Table 2 Mortality and morbidity to discharge for babies of women transferred antenatally and for those who delivered in level 2 and level 3
services without transfer for births in England in 2006 between 22 and 26 weeks of gestation
Outcome
Level 2
(n=829)
Antenatal
transfer
(n=440)
Level 3
(n=947) p Value*
aOR
L3 vs L2
aOR
Level 2 v ANT
aOR
Level 3 vs ANT
Antenatal death 174 21% 45 10% 163 17% 0.104 0.86 (0.66 to 1.13) 1.52 (1.03 to 2.26) 1.31 (0.89 to 1.93)
Delivery room deaths† 143 17% 30 7% 118 12% 0.002 0.53 (0.37 to 0.77) 1.67 (1.02 to 2.72) 0.89 (0.54 to 1.46)
Neonatal unit deaths <7 days 116 14% 50 11% 118 12% 0.005 0.69 (0.51 to 0.94) 1.80 (1.23 to 2.63) 1.25 (0.86 to 1.81)
All early neonatal deaths 259 31% 80 18% 236 25% 0.0001 0.61 (0.47 to 0.79) 1.85 (1.33 to 2.57) 1.12 (0.81 to 1.56)
Late neonatal death (7–28 days)† 56 7% 43 10% 79 8% 0.932 0.94 (0.64 to 1.38) 1.08 (0.69 to 1.68) 1.01 (0.67 to 1.53)
Death 29 days to discharge 35 4% 32 7% 54 6% 0.853 1.08 (0.68 to 1.73) 0.86 (0.50 to 1.46) 0.93 (0.57 to 1.51)
All deaths 524 63% 200 45% 532 56% 0.014 0.75 (0.59 to 0.95) 1.44 (1.09 to 1.90) 1.08 (0.83 to 1.41)
Survival without morbidity 70 8% 65 15% 92 10% 0.086 1.14 (0.80 to 1.61) 0.65 (0.44 to 0.96) 0.74 (0.51 to 1.06)
Survivors only
No morbidity 70 23% 65 27% 92 22% 0.166 0.99 (0.69 to 1.43) 0.72 (0.48 to 1.08) 0.71 (0.49 to 1.04)
Perinatal factors
Antenatal steroid (any) 531/824 64% 412/436 95% 656/936 70% <0.0001 1.15 (0.90 to 1.47) 0.20 (0.12 to 0.31) 0.23 (0.14 to 0.36)
Resuscitation withheld 89/653 14% 12/395 3% 61/784 8% 0.002 0.41 (0.25 to 0.66) 1.25 (0.62 to 2.55) 0.51 (0.24 to 1.09)
Alive with HR>100 at 5 m 463/551 84% 342/379 90% 610/710 86% 0.243 1.16 (0.84 to 1.60) 0.70 (0.46 to 1.06) 0.81 (0.53 to 1.22)
Admitted to NNU 511/829 62% 365/440 83% 664/947 70% 0.014 1.41 (1.09 to 1.81) 0.69 (0.50 to 0.96) 0.98 (0.70 to 1.35)
*p Value for overall significance of transfer adjusted for gestational age and birthweight for gestation.
†Heterogeneity of effect of antenatal transfer across gestational age for two outcomes (p=0.048 for delivery room and p=0.039 for late neonatal deaths).
ANT, antenatal transfer; aOR, OR adjusted for gestational age and birthweight for gestation based on population alive at start of time period.
Table 3 Mortality and morbidity to discharge for neonatal unit admissions for babies who were transferred to a level 3 service after admission
(NNT) compared with babies who remained in their hospital of birth, for births in England in 2006 between 22 and 26 weeks of gestation
Outcome
Level 2
(n=348) (%)
Neonatal
transfer
(n=261)
Level 3
(n=1028) p Value* aOR L3 vs L2 aOR L2 vs NNT aOR L3 vs NNT
Neonatal unit deaths <7 days 80 23% 35 21% 166 16% 0.002 0.56 (0.41 to 0.78) 1.50 (0.93 to 2.42) 0.85 (0.55 to 1.30)
Late neonatal death (7–28 days) 34 10 22 14% 122 12% 0.935 0.93 (0.61 to 1.43) 1.01 (0.55 to 1.86) 0.94 (0.56 to 1.58)
Death 29 days to discharge 22 6 13 8% 86 8% 0.831 1.05 (0.63 to 1.76) 1.16 (0.54 to 2.49) 1.22 (0.64 to 2.34)
All deaths 136 39% 70 43% 374 36% 0.156 0.76 (0.58 to 1.00) 1.25 (0.82 to 1.89) 0.95 (0.66 to 1.37)
Survival without morbidity 58 17% 12 7% 157 15% 0.124 1.09 (0.77 to 1.54) 1.76 (0.90 to 3.46) 1.92 (1.02 to 3.60)
Survivors only
No morbidity 58 27% 12 13% 157 24% 0.172 0.97 (0.67 to 1.40) 1.88 (0.94 to 3.78) 1.83 (0.96 to 3.50)
No heterogeneity was detected for any outcome in the effect of neonatal transfer at different gestational ages.
*p Value for overall significance of transfer adjusted for gestational age and birthweight for gestation.
aOR, OR adjusted for gestational age and birthweight for gestation based on population alive at start of time period; NNT, neonatal transfer.
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Overall, antenatal steroid was administered to 45% of births
in hospitals with level 1, 64% in hospitals with level 2 and 78%
in hospitals with level 3 services. The odds of receiving steroid
are 2.5 times higher for each week of gestational age (OR 2.50
(95% CI 2.29 to 2.72)), controlling for service category, and
1.83 times (95% CI 1.58 to 2.12) higher for each increase in
service level, controlling for gestational age.
Planned no active intervention was recorded in 15% of births
in level 1, 14% in level 2 and 6% in level 3 services. The odds
of there being no active intervention are 0.62 (95% CI 0.47 to
0.82) for each change in service category, controlling for gesta-
tional age.
When comparing births in level 2 services with those trans-
ferred antenatally, mothers less frequently received steroid, a
plan for no active intervention was more frequent and the baby
was less likely to have a heart rate >100 bpm at 5 min (table 2).
Antenatal transfers were also more likely to receive steroid com-
pared with non-transferred level 3 births. CRIB-II scores were
not signiﬁcantly different between groups (not shown), indicat-
ing similarity of the condition of the babies on admission for
neonatal care.
When we considered hospital of booking, babies of women
booked in level 3 services were less likely to have resuscitation
withheld (aOR 0.48 (0.29 to 0.79)) and more likely to be
admitted for neonatal intensive care (aOR 1.31 (1.02 to 1.68)),
but they had similar rates of steroid administration and similar
chances of being alive with a heart rate >100 bpm at 5 min
(aOR 0.97 (0.76 to 1.24) and 1.08 (0.79 to 1.48), respectively).
DISCUSSION
These national data represent the ﬁrst study of outcomes for the
entire perinatal service since neonatal care in England was reor-
ganised into managed clinical networks. Within this reorganisa-
tion there has been much local debate as to the appropriate
setting in which to care for extremely preterm infants. We have
demonstrated that in 2006 only 56.4% of extremely preterm
births occurred in the recommended setting of level 3 services
and that birth in such a service was associated with reduced
mortality, particularly among deaths occurring around delivery
and during the ﬁrst 7 days after birth. Considering the popula-
tion of women booked in level 3 services, greater survival is also
apparent, suggesting that service differences may be important.
Furthermore, differences in survival between high and medium
neonatal activity levels in level 3 services emphasise the import-
ance of the setting in which care takes place.
Whereas survival increased between 1995 and 2006 in babies
born between 22 and 25 weeks of gestation, neonatal morbidity,
in terms of brain injury, bronchopulmonary dysplasia, retinop-
athy and severe necrotising enterocolitis, was unchanged.1 In
this study, the place of birth and perinatal transfer had little
impact on the proportion with morbidities in any setting. It
appears likely that reducing morbidity in this population may
require different strategies from those that have successfully
enhanced survival.
Potential limitations
Comparisons such as this are fraught with difﬁculty. In particu-
lar, the data may be confounded by differences in case mix,
mainly of gestational age and birthweight for gestation, conse-
quent on local demography, women’s choice of place of birth
and both antenatal and postnatal transfers. For this reason, we
have reported comparisons adjusted for gestation and weight for
gestation at birth and, while we have no information about
whether women with health problems or previous adverse preg-
nancy outcomes preferentially ‘booked’ in level 3 services,
because of the detail in the EPICure database we are able to
account for all transfers thereafter. Because we had recorded the
place of booking in the pregnancy, we were also able to correct
for bias that may occur with the transfer out of good prognosis
pregnancies and conﬁrm reduced mortality for babies whose
mothers booked in level 3 services.
It was not possible to determine how many of the births in
level 1 or level 2 services could have been avoided if there had
been a more active approach to the initiation of corticosteroid
therapy and arranging antenatal transfer as soon as extremely
preterm birth was expected. Some births in level 2 services
occurred either because the mother arrived in hospital at too
advanced a stage of labour, with a complication preventing her
safe transfer, or because at 22 or 23 weeks prognosis was con-
sidered too poor to warrant active intervention. Women who
present to the labour ward and rapidly deliver are likely to be
those who receive least steroid and thus have worse neonatal
early lung disease and worse outcomes. Using outcomes based
on hospital of booking, we see no differences in the rate of
steroid use between women booked in level 2 and level 3
services, conﬁrming the bias for those not transferred.
Table 4 Mortality and morbidity to discharge for babies cared for in level 3 services categorised by medium and high-activity levels (see text)
Outcome
High activity
(n=826)
Medium activity
(n=525) aOR high vs medium activity p Value*
Antenatal death 121 15% 85 16% 0.92 (0.66 to 1.27) 0.600
Delivery room deaths* 82 10% 65 12% 0.78 (0.49 to 1.22) 0.274
Neonatal unit deaths <7 days 94 11% 68 13% 0.82 (0.58 to 1.17) 0.275
All early neonatal deaths 176 21% 133 25% 0.78 (0.58 to 1.06) 0.119
Late neonatal death (7–28 days)* 69 8% 50 10% 0.72 (0.47 to 1.08) 0.115
Death 29 days to discharge 49 6% 35 7% 0.65 (0.40 to 1.06) 0.086
All deaths 415 50% 303 58% 0.68 (0.52 to 0.89) 0.005
Survival without neonatal morbidity 86 10% 65 12% 0.79 (0.55 to 1.14) 0.205
Survivors only
No neonatal morbidity 86 21% 65 29% 0.69 (0.47 to 1.02) 0.063
No heterogeneity (of effect of throughput level) was found across gestational age for any outcome.
*Test for significance of effect of throughput, adjusted for gestational age and birthweight for gestation; further adjustment for antenatal transfer did not materially change the ORs or
CIs for any of the outcomes.
aOR, OR adjusted for gestational age and birthweight for gestation based on population alive at start of time period.
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Furthermore, management was more active following antenatal
transfer, perhaps because there was sufﬁcient time for safe trans-
fer and there were higher expectations of a good outcome. Our
data support the safety of antenatal transfer for the baby.
Comparisons with other studies
Most published comparisons,4 including data from the UK,6 7
use neonatal unit admissions as their denominator population,
thereby effectively ignoring policy and competency concerning
perinatal and immediate delivery room care. In these compari-
sons, many use case mix correction strategies, such as CRIB-II,9
to correct for different practices and outcomes in the delivery
room. In our study, for babies admitted to neonatal units,
CRIB-II scores are not signiﬁcantly different between babies
admitted in level 2 and level 3 neonatal units. In contrast, our
ﬁndings suggest that care in the perinatal period is particularly
important in reducing mortality and are consistent with our
reported observation that improvements in mortality of admit-
ted babies between 1995 and 2006 relate to improved mortality
around delivery and during the ﬁrst week after birth.1
An analysis of routinely collected data from neonatal admis-
sions in England has shown increased postnatal transfers of
babies born at 27 and 28 weeks of gestation in 2009 and 2010
compared with data for babies of the same gestation born
between 1998 and 2000 before regionalisation of services.10 It
was notable when comparing the 2006 EPICure cohort of
admissions born before 26 weeks with the previous cohort born
in 1995,1 that there had been an increase in the proportion
transferred within 24 h of birth. However, postnatal transfer in
2006 was not associated with increased morbidity as it had been
in 1995, probably associated with the introduction of network-
based dedicated neonatal transfer teams.
In different health services outside the UK, there is evidence
that centralised services produce better survival outcomes for
babies requiring neonatal intensive care. A recent systematic
review used data from the USA (22 studies) and from the rest of
the world (15 studies, including studies from Canada, Israel,
Australia and Europe, but not the UK). Overall the odds of sur-
vival in level 3 compared with level 2 services were 1.60 (1.33
to 1.92), slightly higher in studies of babies <1000 g birth-
weight (1.80 (1.31 to 2.46)) than in very preterm infants (1.42
(1.06 to 1.88)).4
Our study is based upon the population for whom such trans-
fer is recommended in current guidance.11 Even after excluding
births at 22 weeks, at which gestation active intervention is not
recommended under current guidance,12 and at 26 weeks, for
whom currently transfer is not universal, still only 59% of
births at 23–25 weeks of gestation are born in recommended
settings. In contrast, among liveborn babies born in the Parisian
region of France between 24 and 31 weeks of gestation,
between 1997 and 2003, 77% of births occurred in level 3
centres; inpatient mortality and the prevalence of intraventricu-
lar haemorrhage were signiﬁcantly lower in such centres, while
the rate of periventricular leucomalacia and bronchopulmonary
dysplasia remained constant.13
CONCLUSIONS
In this whole population study, we have demonstrated improved
neonatal survival for babies born between 22 and 26 weeks of
gestation and managed in level 3 services in England, and
further improvements in survival for those babies managed in
level 3 intensive care units with higher levels of activity. These
data support the concept that hospital expertise and activity are
important factors in improved outcomes for high-risk
pregnancies with threatened extremely preterm birth.14 15
Recent UK data conﬁrm that neonatal nurse stafﬁng levels con-
tinue to be associated with quality of care,16 but many of our
level 3 services are smaller than those associated with improved
outcomes.17 Despite this, our successful networks are currently
at risk in the reorganisation of the NHS.18 We speculate that
further development of these structures with larger and appro-
priately staffed neonatal services integrated with maternity net-
works is required if survival for extremely preterm babies is to
continue to improve.
Acknowledgements The EPICure outcome studies were sponsored by the
University of Nottingham (till September 2008) and subsequently by University
College London. NM receives part funding from the Department of Health’s NIHR
Biomedical Research Centre’s funding scheme at UCLH/UCL
Contributors NM and KLC formulated the hypothesis and NM, EMH, ASM and CB
the design of the analysis. CB analysed the data under supervision from EMH and
NM. Perinatal data were collated by KLC, ESD and EMH. NM wrote the ﬁrst draft
and coordinated the manuscript. All authors were involved in interpretation of the
data and writing the report. All have seen and approved the ﬁnal version.
Oversight EPICure Studies Steering Committee Independent Members: Professor
Peter Brocklehurst (Chairman), Mrs Jane Abbott, Professor Andrew Bush, Professor
Richard Cooke, Mrs Noreen Maconochie, Mrs Alison Matthews, Mr David Matthews,
Dr Richard Morton, Dr Maggie Redshaw, Professor David Taylor, Mr Nigel Turner,
Mrs Diane Turner and Mr Patrick Walsh.
Research governance The Medical Research Council funded the study in full
(G0401525) and had no role in study design, data collection, data analysis, data
interpretation, or writing of the report. City and East London REC 3 granted ethical
approval for the EPICure 2 study (05/Q0605/107).
Funding Medical Research Council.
Competing interests None.
Ethics approval City and East London REC 3.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The EPICure Studies have a formal data sharing policy
available from http://www.epicure.ac.uk
Open Access This is an Open Access article distributed in accordance with the
Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which
permits others to distribute, remix, adapt, build upon this work non-commercially,
and license their derivative works on different terms, provided the original work is
properly cited and the use is non-commercial. See: http://creativecommons.org/
licenses/by-nc/3.0/
REFERENCES
1 Costeloe KL, Hennessy EM, Haider S, et al. Short term outcomes after extreme
preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the
EPICure studies). BMJ 2012;345:e7976.
2 Moore T, Hennessy EM, Myles J, et al. Neurological and developmental outcome in
extremely preterm children born in England in 1995 and 2006: the EPICure studies.
BMJ 2012;345:e7961.
3 Marlow N, Bryan Gill A. Establishing neonatal networks: the reality. Arch Dis Child
Fetal Neonatal Ed 2007;92:F137–42.
4 Lasswell SM, Barﬁeld WD, Rochat RW, et al. Perinatal regionalization for very
low-birth-weight and very preterm infants: a meta-analysis. JAMA 2010;304:
992–1000.
5 Department of Health. Report of DH Expert Working Group on neonatal intensive
care services. London: Department of Health, 2003.
6 Selinger M. Beneﬁts of reorganising neonatal and obstetric services are unclear.
BMJ 2012;344:e3203.
7 Tucker J, Tarnow-Mordi W, Gould C, et al. UK neonatal intensive care services in
1996. On behalf of the UK Neonatal Stafﬁng Study Collaborative Group. Arch Dis
Child Fetal Neonatal Ed 1999;80:F233–4.
8 Tyson JE, Parikh NA, Langer J, et al. Intensive care for extreme prematurity—
moving beyond gestational age. NEJM 2008;358:1672–81.
9 Parry G, Tucker J, Tarnow-Mordi W, et al. CRIB II: an update of the clinical risk
index for babies score. Lancet 2003;361:1789–91.
10 Gale C, Santhakumaran S, Nagarajan S, et al. Impact of managed clinical networks
on NHS specialist neonatal services in England: population based study. BMJ
2012;344:e2105.
11 Department of Health. Toolkit for High Quality Neonatal Services. London:
Department of Health, 2009.
Marlow N, et al. Arch Dis Child Fetal Neonatal Ed 2014;99:F181–F188. doi:10.1136/archdischild-2013-305555 F187
Original article
 group.bmj.com on June 11, 2014 - Published by fn.bmj.comDownloaded from 
12 Wilkinson AR, Ahluwalia J, Cole A, et al. Management of babies born extremely
preterm at less than 26 weeks of gestation: a framework for clinical practice at the
time of birth. Arch Dis Child Fetal Neonatal Ed 2009;94:F2–5.
13 Zeitlin J, Ancel PY, Delmas D, et al. Changes in care and outcome of very preterm
babies in the Parisian region between 1998 and 2003. Arch Dis Child Fetal
Neonatal Ed 2010;95:F188–93.
14 Chung JH, Phibbs CS, Boscardin WJ, et al. Examining the effect of hospital-level
factors on mortality of very low birth weight infants using multilevel modeling.
J Perinatol 2011;31:770–5.
15 Finnstrom O, Olausson PO, Sedin G, et al. The Swedish national prospective study
on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and
survival in relation to level of care. Acta Paediatrica 1997;86:503–11.
16 Pillay T, Nightingale P, Owen S, et al. Neonatal nurse stafﬁng and delivery of clinical
care in the SSBC Newborn Network. Arch Dis Child Fetal Neonatal Ed 2012;97:
F174–8.
17 Phibbs CS. Managed clinical networks in neonatal care. BMJ 2012;344:e2423.
18 Boyle R. Clinical networks are effective, work in patients’ interests, and shouldn’t
be disbanded. BMJ 2013;346:f565.
F188 Marlow N, et al. Arch Dis Child Fetal Neonatal Ed 2014;99:F181–F188. doi:10.1136/archdischild-2013-305555
Original article
 group.bmj.com on June 11, 2014 - Published by fn.bmj.comDownloaded from 
doi: 10.1136/archdischild-2013-305555
published online March 6, 2014
 2014 99: F181-F188 originallyArch Dis Child Fetal Neonatal Ed
 
N Marlow, C Bennett, E S Draper, et al.
 
England: the EPICure 2 study
babies in relation to place of birth in 
Perinatal outcomes for extremely preterm
 http://fn.bmj.com/content/99/3/F181.full.html
Updated information and services can be found at: 
These include:
Data Supplement
 http://fn.bmj.com/content/suppl/2014/03/07/archdischild-2013-305555.DC1.html
"Supplementary Data"
References
 http://fn.bmj.com/content/99/3/F181.full.html#related-urls
Article cited in: 
 
 http://fn.bmj.com/content/99/3/F181.full.html#ref-list-1
This article cites 16 articles, 10 of which can be accessed free at:
Open Access
non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
terms, provided the original work is properly cited and the use is
work non-commercially, and license their derivative works on different 
license, which permits others to distribute, remix, adapt, build upon this
Creative Commons Attribution Non Commercial (CC BY-NC 3.0) 
This is an Open Access article distributed in accordance with the
service
Email alerting
the box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on June 11, 2014 - Published by fn.bmj.comDownloaded from 
Collections
Topic
 (804 articles)Neonatal health   
 (279 articles)Neonatal and paediatric intensive care   
 (1342 articles)Child health   
 (825 articles)Epidemiologic studies   
 (24 articles)Open access   
 (34 articles)Editor's choice   
 
Articles on similar topics can be found in the following collections
Notes
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on June 11, 2014 - Published by fn.bmj.comDownloaded from 
